HuGE Literature Finder
Records
1
-
7
Novel variant in glycophorin c gene protects against ribavirin-induced anemia during chronic hepatitis C treatment. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2021 Sep 143 112195. Lin Jennifer J, Loucks Catrina M, Trueman Jessica N, Drögemöller Britt I, Wright Galen E B, Yoshida Eric M, Ford Jo-Ann, Lee Samuel S, Kim Richard B, Al-Judaibi Bandar, Schwarz Ute I, Ramji Alnoor, Tam Edward, Ross Colin J, Carleton Bruce |
Pharmacogenetic analysis of hepatitis C virus related mixed cryoglobulinemia. Pharmacogenomics 2017 Apr . Cusato Jessica, Boglione Lucio, De Nicolò Amedeo, Cardellino Chiara Simona, Carcieri Chiara, Cariti Giuseppe, Di Perri Giovanni, D'Avolio Anton |
Clinical pharmacology of tenofovir clearance: a pharmacokinetic/pharmacogenetic study on plasma and urines. The pharmacogenomics journal 2015 Oct . Calcagno A, Cusato J, Marinaro L, Trentini L, Alcantarini C, Mussa M, Simiele M, D'Avolio A, Di Perri G, Bonora |
Intracellular accumulation of boceprevir according to plasma concentrations and pharmacogenetics. International journal of antimicrobial agents 2015 Jun 45 (6): 657-61. Cusato Jessica, Allegra Sarah, De Nicolò Amedeo, Boglione Lucio, Fatiguso Giovanna, Abdi Adnan Mohamed, Cariti Giuseppe, Di Perri Giovanni, D'Avolio Anton |
Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection. Journal of hepatology 2013 Apr 58 (4): 669-75. Rau Monika, Stickel Felix, Russmann Stefan, Manser Christine N, Becker Philip P, Weisskopf Michael, Schmitt Johannes, Dill Michael T, Dufour Jean-François, Moradpour Darius, Semela David, Müllhaupt Beat, Geier Andreas, |
Negative predictive value of IL28B, SLC28A2, and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG/IFN-RBV treatment. Therapeutic drug monitoring 2012 Dec 34 (6): 6. D?avolio A, Ciancio A, Siccardi M, Smedile A, Simiele M, Cusato J, Baietto L, Marucco DA, Cariti G, Calcagno A, Gonzalez de Requena D, Sciandra M, Troshina G, Caviglia GP, Bonora S, Rizzetto M, Di Perri G |
Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy: protection against anemia in patients with chronic hepatitis C. Pharmacogenetics and genomics 2011 May 21 (5): 289-96. Doehring Alexandra, Hofmann Wolf Peter, Schlecker Christina, Zeuzem Stefan, Sarrazin Christoph, Berg Thomas, Müller Tobias, Herrmann Eva, Geisslinger Gerd, Lötsch Jö |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: